BYD Co (SZ:002594) (HK:1211) shares fell on Monday after the world’s largest electric vehicle (EV) maker reported a sharp slowdown in July sales, fueling concerns over weakening growth momentum.
The Chinese automaker delivered 344,296 vehicles globally last month, up just 0.6% from a year earlier but down 10.1% from June, marking its first monthly drop in six months. The decline comes after a streak of double-digit growth in recent months, signaling potential headwinds in the competitive EV market.
Shenzhen-listed shares slid as much as 3.1% to 102.57 yuan following the announcement. The slowdown was most notable in plug-in hybrid sales, which plunged 22.6% year-on-year and continued to fall month-on-month.
Battery electric vehicles (BEVs) remained a bright spot on an annual basis, with sales climbing 36.8% to 177,887 units. However, BEV sales still fell 14% from June, underscoring fragile demand trends despite strong year-over-year gains.
The softening sales come as Chinese regulators move to tighten oversight of the EV industry. Draft amendments to the national pricing law, unveiled recently, aim to curb below-cost selling and improper algorithm-driven pricing practices to stabilize a market that has been overheated by aggressive competition.
BYD’s results highlight the challenges facing even the sector’s strongest players amid intensifying price wars, shifting consumer demand, and evolving regulatory pressures. Investors will be watching closely to see if the automaker can regain its sales momentum in the coming months as global EV competition heats up.


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Anta Sports Expands Global Footprint With Strategic Puma Stake 



